TWST Stock Analysis: Buy, Sell, or Hold?
TWST - Twist Bioscience Corporation Common Stock
$145.59
9.26 (6.79%)
▲
5d:
+22.79%
30d:
+57.5%
90d:
+147.45%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Get Alerted When TWST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TWST is 17.3% above its trading range ($124.07). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TWST is 17.3% above its trading range ($124.07). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TWST is currently trading at $145.59, which is considered extended relative to its 30-day fair value range of $88.35 to $124.07.
Technical Outlook: Technically, TWST is in a strong uptrend. The price is approaching resistance at $145.93. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: TWST scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $105.30. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TWST is in a strong uptrend. The price is approaching resistance at $145.93. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: TWST scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $105.30. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$88.35 -
$124.07
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
10.5%
Protect Your Profits
Holding TWST? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+17.3% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BEARISH: Trading 27.7% above Wall St target ($105.30)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$88.35 -
$124.07
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$113.18
Resistance Level
$145.93
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-229.89
Wall Street Target
$105.30
(-27.7%)
Revenue Growth (YoY)
23.2%
Profit Margin
-31.7%
Share & Embed Analysis
Last updated: August 22, 2026 9:46 PM ET
Data refreshes hourly during market hours. Next update: 10:46 PM
Data refreshes hourly during market hours. Next update: 10:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TWST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Emily M Leproust
SELL
8061 shares
2026-04-22
Emily M Leproust
SELL
1610 shares
2026-04-21
Adam Laponis
SELL
4000 shares
2026-04-17
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 50 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$331 | 38 SELL |
Advanced TWST Option Strategies
Professional options setups generated by AI based on today's TWST price and gamma walls.
